Stevens–Johnson syndrome in HIV patients treated with nevirapine: two case reports
- 1 May 2002
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (8) , 1197-1198
- https://doi.org/10.1097/00002030-200205240-00022
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Incidence of rash and discontinuation of nevirapine using two different escalating initial dosesAIDS, 1999
- Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infectionClinical Therapeutics, 1998
- Nevirapine and rashesThe Lancet, 1998
- Nevirapine-associated Stevens-Johnson syndromeThe Lancet, 1998
- Thrombocytopenia associated with hepatitis C viral infectionJournal of Hepatology, 1996
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisNew England Journal of Medicine, 1995
- Extrahepatic Immunologic Manifestations in Chronic Hepatitis C and Hepatitis C Virus SerotypesAnnals of Internal Medicine, 1995